Far Sight Group Inc - Medicare Optometrist in Glendale, CA

Far Sight Group Inc is a medicare enrolled "Optometrist" provider in Glendale, California. Their current practice location is 2035 Rangeview Dr, Glendale, California. You can reach out to their office (for appointments etc.) via phone at (818) 439-2024.

Far Sight Group Inc is licensed to practice in California (license number OPT 11567 TPL) and it also participates in the medicare program. Far Sight Group Inc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1073908554.

Contact Information

Far Sight Group Inc
2035 Rangeview Dr,
Glendale, CA 91201-1171
(818) 439-2024
Not Available



Healthcare Provider's Profile

Full NameFar Sight Group Inc
TypeFacility
SpecialityOptometrist
Location2035 Rangeview Dr, Glendale, California
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1073908554
  • Provider Enumeration Date: 04/01/2015
  • Last Update Date: 04/01/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 4688984792
  • Enrollment ID: O20151102001574

Medical Identifiers

Medical identifiers for Far Sight Group Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1073908554NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist OPT 11567 TPL (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Far Sight Group Inc acts as a billing entity for following providers:
Provider NameHamlet Minasvand
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1982885273
PECOS PAC ID: 3375584998
Enrollment ID: I20050517000249

News Archive

TP63 gene correlates significantly with worse prognosis of melanoma

Scientists at Queen Mary, University of London have identified a gene present in some melanoma which appears to make the tumour cells more resistant to treatment, according to research published today in the Journal of Experimental Medicine.

New technology reveals cellular gene transcription process in detail

A new technology that reveals cellular gene transcription in greater detail has been developed by Dr. Daniel Kaufmann of the University of Montreal Hospital Research Centre and the research team he directed. "This new research tool offers us a more profound view of the immune responses that are involved in a range of diseases, such as HIV infection. At the level of gene transcription, this had been difficult, complex and costly to do with current technologies, such as microscopy," explained the University of Montreal professor.

HIV spreading in New York City at about three times the national rate, study finds

HIV is spreading in New York City at about three times the national rate, with an incidence of 72 new HIV infections per 100,000 people, compared with 23 new infections per 100,000 people nationwide, according to a study released Wednesday by the New York City Department of Health and Mental Hygiene, the New York Times reports (Chan, New York Times, 8/28).

Evidence on effectiveness of digital mental health interventions for adolescents remains inconclusive

An increasing number of digital mental health interventions are designed for adolescents and young people with a range of mental health issues, but the evidence on their effectiveness is mixed, according to research by Columbia University Mailman School of Public Health and Spark Street Advisors.

Read more Medical News

› Verified 3 days ago

Provider NameRobert Feher
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1962437202
PECOS PAC ID: 0941348064
Enrollment ID: I20091111000013

News Archive

TP63 gene correlates significantly with worse prognosis of melanoma

Scientists at Queen Mary, University of London have identified a gene present in some melanoma which appears to make the tumour cells more resistant to treatment, according to research published today in the Journal of Experimental Medicine.

New technology reveals cellular gene transcription process in detail

A new technology that reveals cellular gene transcription in greater detail has been developed by Dr. Daniel Kaufmann of the University of Montreal Hospital Research Centre and the research team he directed. "This new research tool offers us a more profound view of the immune responses that are involved in a range of diseases, such as HIV infection. At the level of gene transcription, this had been difficult, complex and costly to do with current technologies, such as microscopy," explained the University of Montreal professor.

HIV spreading in New York City at about three times the national rate, study finds

HIV is spreading in New York City at about three times the national rate, with an incidence of 72 new HIV infections per 100,000 people, compared with 23 new infections per 100,000 people nationwide, according to a study released Wednesday by the New York City Department of Health and Mental Hygiene, the New York Times reports (Chan, New York Times, 8/28).

Evidence on effectiveness of digital mental health interventions for adolescents remains inconclusive

An increasing number of digital mental health interventions are designed for adolescents and young people with a range of mental health issues, but the evidence on their effectiveness is mixed, according to research by Columbia University Mailman School of Public Health and Spark Street Advisors.

Read more Medical News

› Verified 3 days ago

Provider NameSteven Freedman
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1366417503
PECOS PAC ID: 7618026980
Enrollment ID: I20160901002394

News Archive

TP63 gene correlates significantly with worse prognosis of melanoma

Scientists at Queen Mary, University of London have identified a gene present in some melanoma which appears to make the tumour cells more resistant to treatment, according to research published today in the Journal of Experimental Medicine.

New technology reveals cellular gene transcription process in detail

A new technology that reveals cellular gene transcription in greater detail has been developed by Dr. Daniel Kaufmann of the University of Montreal Hospital Research Centre and the research team he directed. "This new research tool offers us a more profound view of the immune responses that are involved in a range of diseases, such as HIV infection. At the level of gene transcription, this had been difficult, complex and costly to do with current technologies, such as microscopy," explained the University of Montreal professor.

HIV spreading in New York City at about three times the national rate, study finds

HIV is spreading in New York City at about three times the national rate, with an incidence of 72 new HIV infections per 100,000 people, compared with 23 new infections per 100,000 people nationwide, according to a study released Wednesday by the New York City Department of Health and Mental Hygiene, the New York Times reports (Chan, New York Times, 8/28).

Evidence on effectiveness of digital mental health interventions for adolescents remains inconclusive

An increasing number of digital mental health interventions are designed for adolescents and young people with a range of mental health issues, but the evidence on their effectiveness is mixed, according to research by Columbia University Mailman School of Public Health and Spark Street Advisors.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Far Sight Group Inc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Far Sight Group Inc
2035 Rangeview Dr,
Glendale, CA 91201-1171

Ph: (818) 439-2024
Far Sight Group Inc
2035 Rangeview Dr,
Glendale, CA 91201-1171

Ph: (818) 439-2024

News Archive

TP63 gene correlates significantly with worse prognosis of melanoma

Scientists at Queen Mary, University of London have identified a gene present in some melanoma which appears to make the tumour cells more resistant to treatment, according to research published today in the Journal of Experimental Medicine.

New technology reveals cellular gene transcription process in detail

A new technology that reveals cellular gene transcription in greater detail has been developed by Dr. Daniel Kaufmann of the University of Montreal Hospital Research Centre and the research team he directed. "This new research tool offers us a more profound view of the immune responses that are involved in a range of diseases, such as HIV infection. At the level of gene transcription, this had been difficult, complex and costly to do with current technologies, such as microscopy," explained the University of Montreal professor.

HIV spreading in New York City at about three times the national rate, study finds

HIV is spreading in New York City at about three times the national rate, with an incidence of 72 new HIV infections per 100,000 people, compared with 23 new infections per 100,000 people nationwide, according to a study released Wednesday by the New York City Department of Health and Mental Hygiene, the New York Times reports (Chan, New York Times, 8/28).

Evidence on effectiveness of digital mental health interventions for adolescents remains inconclusive

An increasing number of digital mental health interventions are designed for adolescents and young people with a range of mental health issues, but the evidence on their effectiveness is mixed, according to research by Columbia University Mailman School of Public Health and Spark Street Advisors.

Read more News

› Verified 3 days ago


Optometrist in Glendale, CA

John J. Mielke, O.d. Inc.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 801 S Chevy Chase Dr Ste 100, Glendale, CA 91205
Phone: 818-956-8785    Fax: 818-956-5367
Dr. Megan Quan, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 409 N Central Ave, Glendale, CA 91203
Phone: 818-265-7755    
Dr. Movses D'janbatian, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 330 N Brand Blvd, Suite 110, Glendale, CA 91203
Phone: 818-241-4921    Fax: 818-241-0468
Jewel City Optometry
Optometrist
Medicare: Medicare Enrolled
Practice Location: 839 N Glendale Ave, Glendale, CA 91206
Phone: 818-240-3937    Fax: 818-240-3933
Ida Simonyan, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 330 N Brand Blvd Ste 110, Glendale, CA 91203
Phone: 708-423-1515    
Dr. Movses D'janbatian, Od, Inc.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 330 N Brand Blvd, Suite 110, Glendale, CA 91203
Phone: 818-241-4921    Fax: 818-241-0468
Dr. Betty Wai-han Lee-villanueva, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 330 N Brand Blvd, Suite 110, Glendale, CA 91203
Phone: 866-260-2020    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.